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I
 
mmunoglobulin (Ig) genes are first modified through the
V(D)J (V, variable; D, diversity; J, joining) recombina-
tion process in pre–B cells. The Rag1/Rag2-dependent
V(D)J recombination generates a large repertoire of B lym-
phocytes, each expressing a unique antibody molecule. Rear-
ranged Ig genes are further modified by the somatic hypermu-
tation process in activated germinal center B lymphocytes.
Through somatic hypermutation, point mutations are in-
troduced into Ig genes at the average frequency of one mu-
tation/10 
 
2
 
 base pairs. After the mutation process, B cells
with nucleotide substitutions resulting in higher affinity an-
tibody are selected for proliferation and differentiation into
memory or plasma cells.
Several molecular features are characteristic of somatic
hypermutation (1). The mutations are mostly single substi-
tutions, very rarely deletions or insertions. Hot spots of
mutation have been observed and of these most notable are
the AGY trinucleotides. Somatic mutation of Ig genes is
confined to a region of 
 
z
 
1.5 kb downstream of the vari-
able region gene promoter. The constant region exon,
which is separated from the variable region exon by several
kb of intron, is usually not targeted for mutation. There
also appears to be a strand bias and A
 
 . 
 
T bias (2). Which
strand is the preferential substrate of the mutation process
has, however, not been determined. Further insights into
the mechanism of somatic hypermutation were made possi-
ble by the use of transgenic mice bearing Ig genes with var-
ious modifications. A transgenic construct with deletion of
the Ig
 
k
 
 intronic enhancer no longer mutates (3). Surpris-
ingly, insertion of an Ig promoter just upstream of the con-
stant region exon results in mutations in the constant re-
gion in addition to the variable region, but sparing of the
region in between (4). The link between promoter prox-
imity and mutation targeting, as well as the evidence of
strand bias and the need for enhancers, strongly suggests
that there is a link between transcription and Ig gene so-
matic hypermutation (4). However, how a mechanism
linked to RNA transcription introduces point mutations
into Ig genes is still largely a mystery, although a role for
RNA polymerase pausing and deposition of a mutator fac-
tor with sequence preferences is suggested by recent find-
ings (Storb, U., E. Klotz, J. Hackett, K. Kage, G. Bozek,
and T.E. Martin, manuscritp submitted for publication).
Several proposals have been made of how DNA repair
might be involved in the somatic hypermutation process.
On the one hand, DNA repair may be used to induce the
mutations. The transcription-linked model proposed by
Peters and Storb (2, 4) suggested the involvement of gratu-
itous transcription-coupled DNA repair where point muta-
tions accumulate through error-prone DNA repair (5, 6).
Cascalho et al. propose that DNA mismatch repair might
be exploited to cause mutations by correcting the unmu-
tated base to be complementary to the mutated base (7).
Cascalho et al. propose no mechanism for the primary in-
troduction of mutations. According to these two models,
diminished DNA repair will result in a decrease in somatic
hypermutation. An opposing view is the proposal that so-
matic mutations of Ig genes cannot be fixed without defi-
ciency in DNA repair (8). In this consideration, somatic
hypermutation could be due to suppressing normal DNA
repair. A proposal made by Gearhart and coworkers takes a
slightly different view of the role of DNA repair, suggest-
ing that DNA mismatch repair in hypermutating cells must
function not to induce mutations but to correct them (9,
10). The authors submit that mutations are introduced into
Ig genes by an error prone DNA polymerase and then
some mutations are repaired by normally functioning DNA
repair mechanisms.
So far, the effort to determine the link between DNA
repair and somatic hypermutation of Ig genes has been
mainly focused on two DNA repair systems, nucleotide ex-
cision repair (NER) and DNA mismatch repair (MMR).
NER is responsible for repairing UV-damaged DNA (11,
12). It was previously shown that NER preferentially re-
pairs the transcribed DNA strand of highly expressed genes
and also that many of the proteins essential for NER func-
tion are also components of the general transcription factor
TFIIH. These observations led to a model of NER that is
coupled to RNA transcription, namely, transcription-cou-
pled repair (TCR; references 5, 6, 13). In TCR, the RNA
polymerase complex, arrested due to a DNA lesion, signals
for recruitment of a DNA repair complex to the site of ar-
rest. Peters and Storb first proposed that such TCR can be
exploited in germinal center B lymphocytes to induce mu-
tation in Ig genes (4). However, experiments with B cells
as well as EBV-transformed human lymphocyte cultures
from patients with defects in NER showed that somatic
mutation appears to be normal despite the severe defect in
NER (8, 14). Human subjects studied include individuals
with mutation in xeroderma pigmentosum (XP)D (8, 14),
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XPB, XPV, or Cockayne syndrome (CS)A (14). XPD and
XPB are required for NER as well as components of the
transcription factor TFIIH. These human subjects show
clear defects in repair of UV-damaged DNA as well as neu-
rological complications (11, 15). XPV appears to be in-
volved in postreplication DNA repair. In cells with mutant
CSA, the preferential repair of the transcribed strand attrib-
uted to TCR function is abolished (11, 15). The apparently
normal frequency of somatic hypermutation in these
NER- or TCR-defective human cells leads to the conclu-
sion that NER does not play a major role in the somatic
hypermutation process. Experiments carried out in knock-
out mice with mutant XPC genes (16) or mutant XPA (9,
17), or XPD genes (17), further support the conclusion that
somatic hypermutation is normal despite the significant de-
crease in NER. Analysis of mice with mutant CSB that
lack functional TCR but not global repair by the NER
machinery (17) again showed that somatic hypermutation
was normal in these mice. It thus appears that NER is not
required for somatic hypermutation, nor for curtailing ex-
cessive mutations.
MMR is best characterized in prokaryotes where MMR
is responsible for correcting errors, short tandem mis-
matches as well as single base pair mismatches, introduced
by the DNA polymerase during DNA replication (18). Key
factors of MMR include MutS, which recognizes mis-
matches, MutH, which is a site-specific endonuclease, and
MutL whose function is poorly understood. MutH, which
recognizes hemimethylated DNA, is responsible for distin-
guishing the newly synthesized DNA strand from the tem-
plate strand. The repair of only the newly synthesized
strand is effective in suppressing the generation of muta-
tions. Search for human and mouse homologues of the
prokaryotic genes have identified multiple homologues of
MutS as well as of MutL, which suggests that there may be
functional redundancy as well as functional specialization
among these homologues. No homologue of MutH has
been identified and it is not yet known how new strand
and template strand of DNA are recognized and distin-
guished in eukaryotes. Several lines of mice with deficient
MMR have been created by gene targeting and these mu-
tant strains show microsatellite instability and high fre-
quency of tumors (19, 20). The analysis of Ig somatic hy-
permutation in these mice, however, seems to yield
conflicting data. Winter et al. studied V
 
k
 
Ox1 genes in
Pms2- (MutL homologue) deficient mice and observed lit-
tle change in mutation frequency compared with normal
mice (9). Similar findings were made in our laboratory
showing normal frequencies of somatic hypermutation in
Pms2- and Mlh1- (another MutL homologue) deficient
mice (Kim, N., and U. Storb, unpublished data). Despite
normal frequencies of mutations in Pms2-deficient mice,
Winter et al. reported an increase in the occurrence of tan-
dem mutations, supporting their view that DNA repair,
MMR in particular, normally functions to correct some of
the mutations introduced into Ig genes in hypermutating cells.
In contrast to the data from Winter et al. and our labora-
tory, Cascalho et al., analyzing somatic hypermutation of
VH genes as well as V
 
l
 
1 genes of the same strain of Pms2-
deficient mice, arrived at a different conclusion (7). Their
data suggest that deficiency in MMR due to mutation of
Pms2 significantly decreases the frequency of somatic hy-
permutation of Ig genes. In this case, it is proposed that
DNA MMR actually functions to fix, rather than correct,
the previously introduced mutations by repairing the un-
mutated strand using the mutated strand as the template.
Unlike the experiments of Winter et al. and of our labora-
tory where the only genetic alteration was in the Pms2 lo-
cus, mice analyzed by Cascalho et al. contained, in addition,
the disruption of the immunoglobulin heavy chain locus at
both alleles, and an insertion into one allele of a functional
VDJ
 
H
 
 resulting in a quasimonoclonal mouse. Can this dif-
ference account for the striking discrepancy between the
data of Winter et al. and Cascalho et al.? Extraordinary cir-
cumstances of selective pressure present in the quasimono-
clonal mice might partly contribute to the different obser-
vations. The fact that somatic mutation is not eliminated in
these mice lends support to this idea.
The data presented in this issue of 
 
The Journal of Experi-
mental Medicine
 
 by Jacobs et al. (17) and Phung et al. (10)
offer yet more points of contention in the topic of the role
of DNA mismatch repair in somatic hypermutation of Ig
genes. Jacobs et al. look at the effect of disruption of the
Msh2 locus on somatic hypermutations of V
 
l
 
1 genes of
memory B lymphocytes. Msh2 is a homologue of MutS
and an essential factor in MMR in eukaryotes. Msh2 can
dimerize with either Msh3 or Msh6 to form a functional
complex that recognizes DNA mismatch. Subsequent re-
pair requires a Mlh1/Pms2 dimer as well as other unidenti-
fied factors. Analysis of 30 V
 
l
 
1 sequences cloned from
memory B cells led Jacobs et al. to conclude that somatic
mutations found in Msh2 null mice were comparable to
those found in wild-type mice. No significant decrease in
mutation frequency was detected. Any change in the oc-
currence of tandem mutations as noted by Winter et al. in
their analysis of PMS2 null mice was also not observed.
The different findings could be due to the fact that Pms2
acts at a downstream step in MMR from the step Msh2 is
involved in as suggested by the authors.
Phung et al. also find that mice with a knockout of the
Msh2 genes do somatically mutate their Ig genes at appar-
ently normal frequency (10). Interestingly, they observe a
skewing in the pattern of mutations. Normally in mice and
humans, somatic mutations from A or T appear about as
frequently as those from G or C. In the Msh2 mice, how-
ever, 
 
z
 
90% of the mutations derive from G or C. As
Phung et al. point out, a similar pattern is apparent in the
Msh2 data from Rajewsky’s laboratory (17). This G or C
nucleotide preference resembles the mutation pattern seen
in Ig genes of cold blooded vertebrates (21, 22). Cold
blooded vertebrates, in contrast to mammals, show very lit-
tle evidence of affinity maturation, i.e., selection of B cells
with favorable Ig gene mutation, presumably due to lack of
germinal centers (21, 22). Is it possible that the GC nucle- 
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otide preference in Msh2-deficient mice is a matter of lack-
ing B cell selection?
We have analyzed the data of Phung et al. with respect
to the changes in sequences from mutant and wild-type
mice. The ratio of silent and replacement mutations is about
the same. Also, the frequency of conservative changes is
about the same in both wild-type and Msh2 mutants. This
may suggest that there is no skewing in the selection of B
cells in the Msh2 mutant mice. Furthermore, as Phung et
al. pointed out, certain codon changes were obviously se-
lected for high affinity to the immunizing antigen as much
in the mutant as in the wild-type mice.
Thus, if the difference in mutation pattern is not due to
selection, it must be due to a direct effect of the MMR
complex, either on the primary mutation mechanism or on
differential correction before the mutations are stabilized in
the genome. We will return below to the question of an
effect of Msh2 on the primary mutation mechanism. Con-
cerning corrections, as Phung et al. note, the data suggest
that G or C are preferentially corrected in wild-type cells,
but not in the mutant cells. Thus, if mutations from G or C
are more frequent in the primary mutation event, they will
make up the majority of mutations in the Msh2 mutant
mice because they are not corrected. This brings up the
burning question of why the overall frequency of muta-
tions is not higher in the Msh2 mutant mice compared
with normal mice. We entertain two possibilities. It may be
that the mutation frequency in many of the functional Ig
genes in the mutant mice is so high that the chance for stop
codons and other detrimental changes is much higher than
normal. A large proportion of cells would thus be elimi-
nated, making the overall number of surviving B cells with
mutations similar to wild type.
However, an analysis of all Ig mutations in the normal
and Msh2 mutant mice (10) suggests an interesting alterna-
tive explanation, namely that the mutant MMR corrects
A- or T-derived mutations much more efficiently than
does the normal MMR. The nucleotides targeted in the
wild-type versus the Msh2 mutant mice are summarized in
Table 1. Clearly, there are very few mutations from A or T
that occur only in the Msh2
 
2/2
 
 mice (6% of all mutations
in the Msh2
 
2/2
 
 mice, column 
 
4
 
) or occur in both the
Msh2
 
2/2
 
 and wild-type mice (6 and 2%, columns 
 
6
 
 and 
 
7
 
).
The vast majority of mutations from A or T occur only in
the wild-type mice (53% of mutations in the wild-type
mice; of the 31 A or T positions that are mutated, 27 are
mutated in wild-type mice [columns 
 
1
 
 and 
 
5
 
] and only 6
are mutated in the Msh2
 
2/2
 
 mice [columns 
 
3
 
 and 
 
5
 
]). On
the other hand, while 92% of the mutations in the Msh2
 
2/2
 
mice are from G or C (column 
 
9
 
), a fairly high proportion
also occur in the wild type (47% of all mutations in wild-
type mice; column 
 
8
 
). This may suggest the following sce-
nario: the wild-type complex Msh2 
 
1 
 
Msh3 or Msh2 
 
1
 
Msh6 may prefer to repair G- or C-derived mismatches
(this implies that the MMR complex can identify the germ-
line-derived G or C), and has little or no activity for the re-
pair of A- or T-derived mismatches. The mutant complex
(minus Msh2; perhaps another protein can combine with
Msh3 and/or Msh6), on the other hand, cannot deal with
G- or C-derived mismatches; however, it has an enhanced
activity for repairing A- or T-derived mismatches. Since in
normal cells the ratio of mutations from A or T versus G or
C is 
 
z
 
1, one would postulate an approximately twofold
excess of mutations from G or C in the primary step of in-
troducing mutations. Thus, the resulting frequency of
overall mutations would be expected to be approximately
the same in the wild type and mutant cells. It would be in-
teresting to test if the substrate specificity of MMR in the
absence of Msh2 is enhanced for A- or T-derived mis-
matches. Returning to coldblooded vertebrates, perhaps
they lack Msh2.
Based on the scenario where wild-type MMR mainly
corrects mutations derived from G or C, and Msh2
 
2/2
 
MMR mainly corrects mutations derived from A or T, the
normal frequency of mutations in Msh2
 
2/2
 
 mice suggests
that MMR plays no significant role in the primary step of
 
Table 1.
 
Nucleotide Changes in Wild-type and Msh2 Mutant Mice
 
*
 
Only in wild type Only in Msh2
 
2
 
/
 
2
 
In both types of mice Total muts
(1)
No. of positions
(2)
Muts
(3)
No. of positions
(4)
Muts
(5)
No. of positions
(6)
Muts wild type
(7)
Muts MS
 
2
 
/
 
2
 
(8)
Wild type
(9)
MS
 
2
 
/
 
2
 
From A/T 25 33 (47)
 
†
 
4 6 (6) 2 4 (6) 2 (2) 37 (53) 8 (8)
From G/C 8 8 (11) 26 46 (46) 16 25 (36) 46 (46) 33 (47) 92 (92)
Total 33 41 (59) 30 52 (52) 18 29 (42) 48 (48) 70 (100) 100 (100)
Columns 
 
1
 
, 
 
3
 
, and 
 
5
 
 show the No. of positions within the total sequence of 276 nucleotides that have the particular mutation.
Columns 
 
2
 
 and 
 
4
 
 show the number (and percentage) of mutations at the indicated Nos. of positions occurring only in wild-type mice (
 
2
 
) or only in
Msh2
 
2
 
/
 
2
 
 mice (
 
4
 
).
Columns 
 
6
 
 and 
 
7
 
 show the mutations in wild-type mice (
 
6
 
) or Msh
 
2
 
/
 
2
 
 mice (
 
7
 
) at positions that show mutations in both types of mice.
Columns 
 
8
 
 and 
 
9
 
 sum up the mutations in the respective row in wild-type (
 
8
 
) or Msh2
 
2
 
/
 
2
 
 mice (
 
9
 
).
 
*
 
Summarized from Fig. 2 of ref. 10 (excludes changes in two codons that were clearly selected for high affinity).
 
‡
 
In parenthesis percent of total mutations in wild-type or Msh2
 
2
 
/
 
2
 
 sequences, respectively. 
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introducing the Ig mutations. This is supported by the
finding that the Msh2
 
2/2
 
 mice have a normal proportion of
mutations in hot spots (of the Ig mutations in the data of
Phung et al. [10] 43% in the mutant mice, and 41% in the
wild-type mice are in the hot spot AGY). Furthermore,
despite the severe reduction in mutations from A or T, the
A
 
 . 
 
T bias and strand bias is preserved in the Msh2
 
2/2
 
mice (10). These conclusions also apply for the Pms2-defi-
cient mice (9). Thus, it appears that MMR is not required
for the primary step of introducing mutations into Ig genes,
but is involved in correcting certain primary mutations.
Furthermore, the presence of hot spots and the A
 
 . 
 
T and
strand biases are apparently properties of the underlying
mechanism of somatic hypermutation (5).
The article by Jacobs et al. (17) also discusses the analysis
of somatic hypermutation in mouse strains lacking func-
tional Rad54-dependent double-strand break repair (DSBR)
or 3-alkyladenine glycosylase (AAG)-mediated base exci-
sion repair (BER). Both mutant strains of mice show nor-
mal frequency and pattern of mutation in their memory B
cell V
 
l
 
1 sequences. However, the possibility remains that
an alternate pathway of BER that does not require AAG
might be involved in somatic hypermutation. Interestingly,
a homologue of bacterial 8-oxoguanine DNA glycosylase
that is involved in BER is highly expressed in germinal
centers and may play a role in somatic mutation (23). An-
other possibility is that PCNA-dependent long patch BER
is involved (12).
Also discussed in the article by Jacobs et al. are mice
lacking poly ADP-ribose polymerase (PARP), which may
bind to a single-strand nick in DNA and is involved in cer-
tain types of DNA repair (12). Even though PARP mutant
mice show sensitivity to ionizing radiation and other DNA
damaging reagents, a “nick sensor” function of PARP must
be redundant (12) and the normal Ig gene mutation fre-
quency and pattern found in PARP mutant mice are not a
clear indication that repair of a single-strand break is not in-
volved in somatic hypermutation.
Identification of 
 
cis
 
-acting factors in the somatic hyper-
mutation process has seen great success through the use of
Ig transgenes (for review see reference 24). Identification of
 
trans
 
-acting factors, however, has proven to be much more
difficult. The lack of an in vitro system has been the main
hurdle in this pursuit. So far, little detail is known about the
molecular mechanism of somatic hypermutation. The re-
port of altered mutation frequency or mutation pattern in
Pms2 and Msh2 mutant mice is the first evidence of 
 
trans
 
-
acting factors involved in somatic hypermutation. A very
careful analysis to reconcile the conflicting results and to
identify the exact nature of the effect Pms2 or Msh2 on so-
matic hypermutation will be necessary. Using a passenger
transgene that is not under selective pressure (25, and
Storb, U., E. Klotz, J. Hackett, K. Kage, G. Bozek, and
T.E. Martin, manuscript submitted for publication) will help
greatly in deciphering the role of Pms2 and Msh2 in Ig hy-
permutation.
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